(1) Triumf University of British Columbia, Vancouver, B.C., (Canada);(2) Department of Pharmaceutical Sciences, University of British Columbia, Vancouver, B. C., (Canada);(3) NASA-Lewis Research Centre, Cleveland, Ohio, (USA)
Abstract:
A facility for the continuous production of iodine-123 by spallation of elemental caesium by 482 MeV protons has been in operation
at a TRIUMF beam dump for about 2 years. Radioxenon from the target is efficiently trapped on alumina which is subsequently
used to remove the121Te decay product. The yield is 100 mCi/h from a 20 gm/cm2 target at 10 μA. Impurities are125I<2% and121Te<0.2% at 27 hours after end of production. The123I consists mainly of iodide along with significant iodate impurity. The product is used extensively in Canadian clinics for
thyroid analyses and for labelling radiopharmaceuticals.